Menu

feburic国内价格

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

feburic (febuxostat, febuxostat) is a xanthine oxidase (XO) inhibitor that is most suitable for people with excessive uric acid production. Based on blood uric acid levels and urinary uric acid excretion, hyperuricemia can be divided into three types: poor uric acid excretion type, excessive uric acid production type, and mixed type. Feburic reduces blood uric acid levels by selectively inhibiting xanthine oxidase, reducing uric acid production, and is most suitable for people with excessive uric acid production.

The starting doses of feburic can be 40mg/day and 80mg/day, with the 80mg dose being more effective for severe patients. If the serum uric acid level is still higher than 6 mg/dL after taking 40 mg/day for 2 weeks, you can take 80 mg/day.

Judging from official clinical trials, the effectiveness of feburic in the general population is about 70%, which is much higher than that of allopurinol. And compared to placebo, there was a clear difference. Clinical trial data on more than 3,000 people show that feburic can effectively reduce uric acid in the blood to 360 μmol/L after taking the medicine for six months.

Feburic was approved for sale in the United States in 2009 and has now been approved for sale in my country. Many patients also want to know the domestic price of feburic.

The price of feburic (febuxostat, febuxostat) original drug is relatively high in my country. The price of Japan’s original feburic (febuxostat/febuxostat) drug is around $1,500. The feburic produced by Zydus Pharmaceutical Factory in India has the same efficacy as the original drug, but the price is relatively low. The specification is 80mg*30 tablets/box, and the price is around 200$. Due to the floating exchange rate, please consult the medical companion for the specific price.

The above is the price introduction of feburic. If you need to buy the Indian version, you can consult the Medical Partner Travel Overseas Medical Consulting Service Company for specific information.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。